Evidence map›Paper›PMID 34371848›Full record

ReviewNutrients2021

Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health.

Iuliia Pavlovska, Anna Polcrova, Jeffrey I Mechanick, Jan Brož, Maria M Infante-Garcia, Ramfis Nieto-Martínez, Geraldo A Maranhao Neto, Sarka Kunzova, Maria Skladana, Jan S Novotny and 6 more

Abstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Trends in obesity-related cancer burden in Czechia.Wiener klinische Wochenschrift · 2023
    Article
  5. Article
  6. Association of Self-Reported Depression Symptoms with Physical Activity Levels in Czechia.International journal of environmental research and public health · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Iuliia PavlovskaInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.ORCID 0000-0003-3730-3817
Anna PolcrovaInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.
Jeffrey I MechanickThe Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jan BrožDepartment of Internal Medicine, Charles University Second Faculty of Medicine, 10506 Prague, Czech Republic.ORCID 0000-0003-2465-7333
Maria M Infante-GarciaInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.
Ramfis Nieto-MartínezFoundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Barquisimeto 3001, Lara, Venezuela.
Geraldo A Maranhao NetoInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.
Sarka KunzovaInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.ORCID 0000-0003-1868-5856
Maria SkladanaInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.ORCID 0000-0001-5008-3279
Jan S NovotnyInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.ORCID 0000-0001-5074-8971
Hynek PikhartResearch Centre for Toxic Compounds in the Environment (RECETOX), Masaryk University, 62500 Brno, Czech Republic.
Jana UrbanováCenter for Research in Diabetes, Metabolism and Nutrition, Second Department of Internal Medicine, Third Faculty of Medicine, University Hospital Královské Vinohrady, 10000 Prague, Czech Republic.ORCID 0000-0002-8860-6124
Gorazd B StokinInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.
Jose R Medina-InojosaDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-8705-0462
Robert VysokyDepartment of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic.
Juan P González-RivasInternational Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic.ORCID 0000-0001-7676-7900

Funding

ENOCH CZ.02.1.01/0.0/0.0/16_019/0000868European Regional Development Fund CZ.1.05/1.1.00/02.0123Ministerstvo Zdravotnictví Ceské Republiky NT13434-4/2012National Program of Sustainability II (MEYS CR) LQ1605
6 · The paper itself

Abstract

In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.

Indexed as

AdiposityAdultCardiometabolic Risk FactorsCardiovascular DiseasesChronic DiseaseCzech RepublicDiabetes Mellitus, Type 2DietDyslipidemiasFeeding BehaviorFemaleGlucose IntoleranceHealth LiteracyHealth Status DisparitiesHumansHypertensionadipositycardiometabolic riskcardiovascular diseasechronic diseasedysglycemiainsulin resistancenutritionobesitytype 2 diabetes

Identifiers

PMID34371848
PMCPMC8308692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.